Patra K, Greene M M, Silvestri J M
Rush University Medical Center, Department of Pediatrics, Chicago, IL, USA.
J Perinatol. 2015 Jan;35(1):77-81. doi: 10.1038/jp.2014.133. Epub 2014 Jul 31.
Postnatal steroids are used in neonatal intensive care units despite known side effects. Hydrocortisone (HC) use persists as it is believed to have less deleterious effects on neurodevelopmental (ND) outcome compared to other steroids. The literature is sparse with respect to the ND impact of HC use in recent years. Hence, we sought to examine the effect of HC use on ND outcome in a contemporary cohort of extremely low birth weight (ELBW) infants.
A total of 175 ELBW infants (86 HC exposed, 89 steroid naive) born in 2008 to 2010 were compared for mortality, morbidity and ND outcome at 8 and 20 months corrected age. Outcome measures included neurologic exam and results of the Bayley Scales of Infant and Toddler Development-III (BSITD-III). Multiple regression analyses adjusted for the effect of other risk factors on outcome.
Overall, 65 (75%) of the HC and 74 (83%) of the no-HC groups survived to discharge. HC infants were smaller (mean birth weight (BW) 719 ± 127 g vs 837 ± 99 g) and of lower gestational age (GA) (mean GA 26.0 ± 1.7 weeks vs 27.5 ± 1.8 weeks) compared to the no-HC group. Patients in the HC group were more likely to be a multiple, have a severely abnormal head ultrasound, bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis and receive treatment for patent ductus arteriosus and hypotension than those in the no-HC group. Of the HC group, the mean age at treatment was 20 ± 19 days, mean duration of treatment 49 ± 37 days. At 8 months, the HC group had lower mean motor (87 ± 18 vs 95 ± 15, P = 0.028) and fine motor (9 ± 2.9 vs 10.5 ± 2.6, P = 0.005) and higher rate of subnormal motor (44 vs 15%, P = 0.002) and fine motor scores (24 vs 6.5%, P = 0.017). In regression analyses, HC exposure >7 days was significantly related to worse outcome on fine motor scores at 8 months while cumulative days of HC exposure was a predictor of worse outcome on language at 8 months and motor outcome at 20 months. Each additional day of HC exposure increased the odds of subnormal receptive and expressive language in the first year of life by 4 and 2%, respectively, and increased odds of subnormal motor function by 2% in the 2nd year of life.
HC exposure for >7 days is associated with worse performance in fine motor skills in the first year of life, while cumulative HC exposure negatively impacts receptive and expressive language skills in the first year and motor skills in the second year of life after adjusting for neonatal and social risk factors.
尽管已知有副作用,但产后类固醇仍用于新生儿重症监护病房。氢化可的松(HC)的使用仍在持续,因为人们认为与其他类固醇相比,它对神经发育(ND)结局的有害影响较小。近年来,关于使用HC对ND影响的文献较少。因此,我们试图在当代极低出生体重(ELBW)婴儿队列中研究使用HC对ND结局的影响。
比较了2008年至2010年出生的175例ELBW婴儿(86例暴露于HC,89例未使用类固醇)在矫正年龄8个月和20个月时治疗的死亡率、发病率和ND结局。结局指标包括神经学检查以及贝利婴幼儿发育量表第三版(BSID-III)的结果。多元回归分析对其他风险因素对结局的影响进行了校正。
总体而言,HC组65例(75%)和非HC组74例(83%)存活至出院。与非HC组相比,HC组婴儿出生时体重更小(平均出生体重(BW)719±127g对837±99g),胎龄(GA)更低(平均GA 26.0±1.7周对27.5±1.8周)。与非HC组相比,HC组患者更可能为多胎,头部超声严重异常,患有支气管肺发育不良、早产儿视网膜病变、坏死性小肠结肠炎,并且接受动脉导管未闭和低血压治疗。在HC组中,治疗的平均年龄为20±19天,平均治疗持续时间为49±37天。在8个月时,HC组的平均运动(87±18对95±15,P = 0.028)和精细运动(9±2.9对10.5±2.6,P = 0.005)得分更低,运动和精细运动评分低于正常水平的比例更高(44%对15%,P = 0.002和24%对6.5%,P = 0.017)。在回归分析中,暴露于HC超过7天与8个月时精细运动评分较差显著相关,而HC暴露的累积天数是8个月时语言结局较差和20个月时运动结局较差的预测指标。HC暴露每增加一天,生命第一年接受性和表达性语言低于正常水平的几率分别增加4%和2%,生命第二年运动功能低于正常水平的几率增加2%。
校正新生儿和社会风险因素后,暴露于HC超过7天与生命第一年精细运动技能表现较差有关,而HC的累积暴露对生命第一年的接受性和表达性语言技能以及生命第二年的运动技能有负面影响。